5013

0

WALPAR

img img img img
No Data Available

WALPAR NUTRITIONS LIMITED Share Price Update

As of the latest trading session, WALPAR NUTRITIONS LIMITED is trading at ₹32.95, down by ₹-1.70 or -4.90% from its previous close. The stock has moved between ₹32.95 and ₹36.35 today. Over the past year, the stock has delivered a return of -21.78%. In the last month, it has returned -9.05%.

WALPAR NUTRITIONS LIMITED performance

Today’s low Today’s high
₹ 32.95 ₹ 36.35
₹ 32.95
52 week low 52 week high
₹ 31.35 ₹ 53.30
₹ 32.95
Open Price ₹ 36.35
Prev. Close ₹ 34.65
Volume (Shares) 8000.00
Total traded value ₹ 2.63
Upper Circuit ₹ 36.35
Lower Circuit ₹ 32.95
info

Investment Returns

Over 1 Month -9.05% Over 3 Months -19.88% Over 6 Months -16.00% Over 1 Year -21.78%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

WALPAR NUTRITIONS LIMITED fundamentals


  • Market cap (Cr) 30.90
  • P/E Ratio (TTM) 19.25
  • Beta 0.62
  • Book Value / share 15.99
  • Return on equity 11.92%
  • EPS (TTM) 1.80
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

WALPAR NUTRITIONS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 65.30
Operating Expense 62.92
Net Profit 1.97
Net Profit Margin (%) 3.01
Earnings Per Share (EPS) 2.09
EBITDA 3.04
Effective Tax Rate (%) 21.82
Particulars MAR 2025 (Values in Cr)
Revenue 60.16
Operating Expense 57.83
Net Profit 1.69
Net Profit Margin (%) 2.80
Earnings Per Share (EPS) 1.80
EBITDA 2.94
Effective Tax Rate (%) 30.45
Particulars MAR 2024 (Values in Cr)
Revenue 51.31
Operating Expense 49.97
Net Profit 1.11
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 2.38
EBITDA 1.90
Effective Tax Rate (%) 25.00
Particulars MAR 2023 (Values in Cr)
Revenue 28.70
Operating Expense 28.51
Net Profit 0.29
Net Profit Margin (%) 1.01
Earnings Per Share (EPS) 0.65
EBITDA 1.05
Effective Tax Rate (%) 34.78
Particulars MAR 2022 (Values in Cr)
Revenue 26.76
Operating Expense 26.45
Net Profit 0.42
Net Profit Margin (%) 1.56
Earnings Per Share (EPS) 0.99
EBITDA 1.10
Effective Tax Rate (%) -23.52
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.63
ROE % 18.21
ROCE % 17.78
Total Debt to Total Equity 0.53
EBITDA Margin 8.35
Particulars MAR 2024 (Values in Cr)
Book Value / Share 30.21
ROE % 15.06
ROCE % 14.25
Total Debt to Total Equity 0.72
EBITDA Margin 7.95
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.80
ROE % 7.14
ROCE % 9.44
Total Debt to Total Equity 0.77
EBITDA Margin 10.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.21
ROE % 4.57
ROCE % 4.98
Total Debt to Total Equity 0.93
EBITDA Margin 3.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.30
ROE % 3.14
ROCE % 2.77
Total Debt to Total Equity 1.57
EBITDA Margin 7.58
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.99
ROE % 11.92
ROCE % 17.64
Total Debt to Total Equity 0.01
EBITDA Margin 4.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.40
ROE % 9.00
ROCE % 11.99
Total Debt to Total Equity 0.14
EBITDA Margin 3.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 24.92
ROE % 2.60
ROCE % 5.28
Total Debt to Total Equity 0.34
EBITDA Margin 3.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.29
ROE % 5.31
ROCE % 6.39
Total Debt to Total Equity 0.62
EBITDA Margin 4.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 14.30
ROE % 3.14
ROCE % 3.32
Total Debt to Total Equity 1.14
EBITDA Margin 7.58
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.58
Total Assets 47.38
Total Liabilities 47.38
Total Equity 19.27
Share Outstanding 0
Price to Book Ratio 2.65
Return on Assets (%) 4.90
Return on Capital (%) 8.57
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 37.16
Total Liabilities 37.16
Total Equity 16.42
Share Outstanding 0
Price to Book Ratio 3.71
Return on Assets (%) 4.25
Return on Capital (%) 6.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 34.30
Total Liabilities 34.30
Total Equity 13.59
Share Outstanding 0
Price to Book Ratio 2.03
Return on Assets (%) 1.72
Return on Capital (%) 2.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 28.09
Total Liabilities 28.09
Total Equity 12.60
Share Outstanding 0
Price to Book Ratio 1.11
Return on Assets (%) 1.35
Return on Capital (%) 1.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.97
Total Assets 18.00
Total Liabilities 18.00
Total Equity 4.80
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.83
Return on Capital (%) 1.22
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 30.92
Total Liabilities 30.92
Total Equity 15.01
Share Outstanding 0
Price to Book Ratio 2.65
Return on Assets (%) 5.47
Return on Capital (%) 11.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 23.49
Total Liabilities 23.49
Total Equity 13.33
Share Outstanding 0
Price to Book Ratio 3.71
Return on Assets (%) 4.73
Return on Capital (%) 8.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 21.85
Total Liabilities 21.85
Total Equity 11.31
Share Outstanding 0
Price to Book Ratio 2.03
Return on Assets (%) 1.34
Return on Capital (%) 2.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.34
Total Assets 23.35
Total Liabilities 23.35
Total Equity 11.03
Share Outstanding 0
Price to Book Ratio 1.11
Return on Assets (%) 1.79
Return on Capital (%) 2.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.97
Total Assets 15.69
Total Liabilities 15.69
Total Equity 4.77
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.96
Return on Capital (%) 1.47
Particulars MAR 2024 (Values in Cr)
Net Income 2.49
Cash from Operations 5.52
Cash from Investing -3.60
Cash from Financing -1.77
Net change in Cash -0.03
Free Cash Flow 7.39
Particulars MAR 2023 (Values in Cr)
Net Income 1.11
Cash from Operations 1.17
Cash from Investing -3.44
Cash from Financing 2.41
Net change in Cash 0.07
Free Cash Flow 6.42
Particulars MAR 2022 (Values in Cr)
Net Income 0.27
Cash from Operations -1.01
Cash from Investing -6.14
Cash from Financing 6.71
Net change in Cash -0.51
Free Cash Flow 2.82
Particulars MAR 2021 (Values in Cr)
Net Income 0.16
Cash from Operations -0.31
Cash from Investing -2.01
Cash from Financing 2.95
Net change in Cash 0.62
Free Cash Flow 1.55
Particulars MAR 2025 (Values in Cr)
Net Income 2.43
Cash from Operations 3.04
Cash from Investing -1.23
Cash from Financing -0.41
Net change in Cash 1.06
Free Cash Flow 4.27
Particulars MAR 2024 (Values in Cr)
Net Income 1.47
Cash from Operations 3.24
Cash from Investing -0.88
Cash from Financing -2.18
Net change in Cash 0.07
Free Cash Flow 4.09
Particulars MAR 2023 (Values in Cr)
Net Income 0.45
Cash from Operations 1.16
Cash from Investing 0.45
Cash from Financing -1.51
Net change in Cash 0.03
Free Cash Flow 1.32
Particulars MAR 2022 (Values in Cr)
Net Income 0.33
Cash from Operations -0.25
Cash from Investing -4.58
Cash from Financing 4.26
Net change in Cash -0.63
Free Cash Flow -0.09
Particulars MAR 2021 (Values in Cr)
Net Income 0.16
Cash from Operations 1.37
Cash from Investing -0.69
Cash from Financing -0.06
Net change in Cash 0.62
Free Cash Flow 1.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA IND LT 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

WALPAR NUTRITIONS LIMITED shareholding pattern

Holding
31.18%
68.81%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

WALPAR NUTRITIONS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
32.95 -4.90 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 34.80
  • 26 Days 38.70
  • 10 Days 35.90
  • 50 Days 40.70
  • 12 Days 36.40
  • 100 Days 42.80
  • 20 Days 37.90
  • 200 Days 45.10
33.55 PIVOT
First Support 32.45 First Resistance 35.75 Second Support 30.25 Second Resistance 36.85 Third Support 29.15 Third Resistance 39.05
RSI 34.45 ADX 34.64 MACD -2.35 Williams % R -65.08 Commodity Channel Index (CCI) -117.27
Date 2026-05-27 Week 5000.00 Same Day 8000.00 Month 4364.00
1 Year 0.62 3 Year 0.27
Over 1 Month
-9.05% down
Over 1 Year
-21.78% down
Over 3 Months
-19.88% down
Over 3 Years
-7.07% down
Over 6 Months
-16.00% down
Over 5 Years
3.98% down

WALPAR NUTRITIONS LIMITED Corporate Actions

Ex-Date Ex-Bonus Ratio
14 Aug 2024 14 Aug 2024 1:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Walpar Nutritions Ltd?

Answer Field

Walpar Nutritions Ltd share price is for NSE ₹ 32.95 & for BSE ₹ 0.00 as on May 29 2026 02:46 PM.

What is the Market Cap of Walpar Nutritions Ltd Share?

Answer Field

The market cap of Walpar Nutritions Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 29 2026 02:46 PM.

What is the 52 Week High and Low of Walpar Nutritions Ltd?

Answer Field

The 52 Week High and Low of Walpar Nutritions Ltd for NSE is ₹ 53.30 and ₹ 31.35 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Walpar Nutritions Ltd?

Answer Field

The 1 year returns on the stock has been -21.78%.

What is the P/E Ratio of Walpar Nutritions Ltd Share?

Answer Field

As on May 29 2026 02:46 PM the price-to-earnings (PE) ratio for Walpar Nutritions Ltd share is 19.25.

What is the PB ratio of Walpar Nutritions Ltd Share?

Answer Field

As on May 29 2026 02:46 PM, the price-to-book (PB) ratio for Walpar Nutritions Ltd share is 15.99.

How to Buy Walpar Nutritions Ltd Share?

Answer Field

You can trade in Walpar Nutritions Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Walpar Nutritions Ltd Share on Bajaj Broking App?

Answer Field

To buy Walpar Nutritions Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Walpar Nutritions Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|